Jesús Rodríguez-Baño to Escherichia coli Infections
This is a "connection" page, showing publications Jesús Rodríguez-Baño has written about Escherichia coli Infections.
Connection Strength
2.147
-
Intestinal colonization due to Escherichia coli ST131: risk factors and prevalence. Antimicrob Resist Infect Control. 2018; 7:135.
Score: 0.568
-
Population pharmacokinetics and pharmacodynamics of fosfomycin in non-critically ill patients with bacteremic urinary infection caused by multidrug-resistant Escherichia coli. Clin Microbiol Infect. 2018 Nov; 24(11):1177-1183.
Score: 0.545
-
Bacteraemia due to non-ESBL-producing Escherichia coli O25b:H4 sequence type 131: insights into risk factors, clinical features and outcomes. Int J Antimicrob Agents. 2017 Apr; 49(4):498-502.
Score: 0.505
-
Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge. Clin Infect Dis. 2006 Dec 01; 43(11):1407-14.
Score: 0.246
-
Prevalence and transmission dynamics of Escherichia coli ST131 among contacts of infected community and hospitalized patients. Clin Microbiol Infect. 2018 Jun; 24(6):618-623.
Score: 0.131
-
Escherichia coli: an old friend with new tidings. FEMS Microbiol Rev. 2016 07 01; 40(4):437-463.
Score: 0.120
-
MIC of amoxicillin/clavulanate according to CLSI and EUCAST: discrepancies and clinical impact in patients with bloodstream infections due to Enterobacteriaceae. J Antimicrob Chemother. 2017 05 01; 72(5):1478-1487.
Score: 0.032